Company Monitoring Page for Illumina

latest headlines for company on cafepharma

Esmo 2022 – Galleri’s real-world exhibition disappoints
EP Vantage
Fri, 09/9/22 - 10:39 am
Tags:
ESMO, Grail, Illumina, diagnostics, multi-cancer test, Galleri
Illumina’s hold on Grail depends now on separate appeals in US, Europe
BioSpace
Thu, 09/8/22 - 10:43 am
Tags:
Illumina, Grail, M&A, Europe
EU swats down Illumina's $8B Grail acquisition days after FTC lost antitrust case
Endpoints
Tue, 09/6/22 - 10:36 am
Tags:
Europe, Illumina, Grail, FTC, M&A
Illumina defeats F.T.C. in major antitrust case
NY Times, NY
Thu, 09/1/22 - 07:46 pm
Tags:
Illumina, FTC, Grail, M&A, antitrust
7 of the Most Shocking M&A Rumors in Medtech
Medical Devices and Diagnostics Industry
Thu, 08/4/22 - 06:38 pm
Tags:
Medtech, M&A, DexCom, Insulet, Medtronic, LivaNova, Baxter, Hill-Rom, Stryker, Boston Scientific, Illumina, Grail, Guardant Health, NeoGenomics, Smith & Nephew
Can Illumina Hold on to Grail?
Medical Devices and Diagnostics Industry
Tue, 08/2/22 - 12:01 am
Tags:
Illumina, Grail, M&A, Europe, antitrust
EC’s Investigation into Illumina/Grail Merger Isn’t Stopping Anytime Soon
Medical Devices and Diagnostics Industry
Mon, 07/18/22 - 09:58 am
Tags:
Illumina, Grail, Europe, M&A
Illumina loses challenge to block EU antitrust probe into $8B Grail buyout
Endpoints
Thu, 07/14/22 - 10:53 am
Tags:
Illumina, M&A, Grail, Europe, antitrust
6 Medtech Acquisitions That Went Horribly Wrong
Medical Devices and Diagnostics Industry
Thu, 07/7/22 - 08:10 pm
Tags:
devices, Medtech, M&A, Medtronic, HeartWare, Second Sight Medical, Pixium Vision, Illumina, PacBio, Novartis, Alcon, Transcend, Organovo, Tarveda Therapeutics, Boston Scientific, Guidant
Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome
BioSpace
Wed, 06/22/22 - 10:26 am
Tags:
Medtech, diagnostics, Illumina, Myriad Genetics, TruSight Oncology 500, cancer, Merck
Illumina Obtains CDx Pan-Cancer Indication for TruSight Test
Medical Devices and Diagnostics Industry
Wed, 05/25/22 - 10:38 am
Tags:
Illumina, Medtech, diagnostics, TruSight Oncology, cancer, companion diagnostics
Illumina forced to pay almost $334M as it loses DNA sequencing patent case
Endpoints
Mon, 05/9/22 - 11:28 pm
Tags:
Medtech, DNA sequencing, patents, Illumina, Complete Genomics
Illumina secures drug discovery tie-ups with Janssen, Deerfield
Biopharma Reporter
Mon, 05/9/22 - 10:11 am
Tags:
Illumina, Janssen, JNJ, Deerfield Management, drug discovery
Illumina and Deerfield Team Up to Utilize AI, Genomics in Drug Development
BioSpace
Fri, 05/6/22 - 10:48 am
Tags:
Illumina, Deerfield, R&D, drug discovery, artificial intelligence
Illumina sues Guardant CEOs over trade secrets, sparking counterblast against 'retaliatory' lawsuit
Medtech Dive
Fri, 03/18/22 - 10:46 am
Tags:
Illumina, Guardant Health, trade secrets, legal, M&A, Grail
Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe
BioSpace
Tue, 03/15/22 - 10:45 am
Tags:
Illumina, Medtech, diagnostics, Europe, TruSight Oncology, cancer, oncology
PacBio is in it for the long run
EP Vantage
Tue, 02/1/22 - 10:13 am
Tags:
Pacific Biosciences, DNA sequencing, Illumina, Medtech
The top 10 medtech M&A deals of 2021
Fierce Biotech
Tue, 01/18/22 - 10:35 am
Tags:
devices, Medtech, M&A, Thermofisher, PPD, 23andMe, PerkinElmer, BioLegend, Illumina, Grail, Baxter International, Hill-Rom, Steris, Cantel Medical, Siemens Healthineers, Varian Medical Systems
Ahead of expected EU objections, Illumina defends Grail acquisition
Endpoints
Wed, 11/17/21 - 11:45 pm
Tags:
Illumina, Grail, M&A, Europe
Illumina Makes First Imprint on GRAIL with New CEO
BioSpace
Fri, 10/15/21 - 11:09 am
Tags:
Grail, Illumina, Bog Ragusa

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.